Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Allergy, Asthma and Clinical Immunology is Scopus-indexed (Q2, CiteScore 4.9), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1710-1484Verify ISSN ↗1710-1492Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 52 / 165 | 68th | Q2 |
| Immunology and Allergy | 112 / 234 | 52nd | Q2 |
| Immunology | 126 / 243 | 48th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q2, CiteScore 4.9.
Allergy, Asthma and Clinical Immunology is Q2 in Pulmonary and Respiratory Medicine (rank 52 of 165), Q2 in Immunology and Allergy (rank 112 of 234) and Q3 in Immunology (rank 126 of 243), by CiteScore 2025.
Allergy, Asthma and Clinical Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.740, quartile Q2, with an H-index of 61.
The publisher lists an article processing charge of about US$3,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Allergy, Asthma and Clinical Immunology is published by BioMed Central Ltd. Its print ISSN is 1710-1484 and its online ISSN is 1710-1492.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Allergy, Asthma and Clinical Immunology has an h-index of 75 and a 2-year mean of 3.14 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #24 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Allergy, Asthma and Clinical Immunology published 66 papers in 2025; its busiest recent year was 2021 with 136. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from Canada (40.3%), Japan (7.2%) and United States (5.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 8 retracted papers are recorded (4.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.